ARKG

ARK Genomic Revolution Multi-Sector ETF

Up$28.61
+$0.05
(+0.18%)
As of 6:30:00 PM EDT | 10/14/19  |  Market Closed

ARKG Trading Data

Open

$28.53

Low Price

$28.3

High Price

$28.98

Previous Last Price

$28.56

Bid Size

$25.61 X 300

Ask Size

$34.6 X 100

ARKG Portfolio Data

AUM

$375,116,500

Shares

13,255

PE Ratio

0

Price / Book Ratio

5.65

Expense Ratio

0.75

Net Asset Value

$28.30

Volume

Volume

51,635

Avg. Volume (YDT)

134,399

Dollar Volume

$2,112,524

Weekly Avg. Volume

70,160

Monthly Avg. Volume

83,475

Quarterly Avg. Volume

106,375

ARKG Fund Description

The ARK Genomic Revolution Multi-Sector ETF seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund?s investment theme of the genomics revolution.

ARKG Chart

ARKG Summary

Fund Family

Ark Funds

Tracks This Index

ARK Genomic Revolution Multi-Sector ETF

Inception Date

2014-11-04

Asset Class

Portfolio-Multi Asset

Asset Class Size

Biotech

ARKG Classification

Region (General)

Global

Region (Specific)

Sector

Multi-Sector

Equity Index

Leveraged Family

ARKG Holdings

Top 10 Holdings

ILLUMINA INC (ILMN)
12.73%
INVITAE CORP (NVTA)
8.04%
CRISPR THERAPEUTICS AG (CRSP)
6.61%
INTELLIA THERAPEUTICS INC (NTLA)
5.46%
TELADOC HEALTH INC (TDOC)
5.28%
EDITAS MEDICINE INC (EDIT)
4.83%
VERACYTE INC (VCYT)
3.99%
IOVANCE BIOTHERAPEUTICS INC (IOVA)
3.89%
ARCTURUS THERAPEUTICS HOLDIN (ARCT UQ)
3.57%
COMPUGEN LTD (CGEN)
3.33%

Total ARKG Holdings

Total Holdings: 36

ILLUMINA INC (ILMN)
12.73%
INVITAE CORP (NVTA)
8.04%
CRISPR THERAPEUTICS AG (CRSP)
6.61%
INTELLIA THERAPEUTICS INC (NTLA)
5.46%
TELADOC HEALTH INC (TDOC)
5.28%
EDITAS MEDICINE INC (EDIT)
4.83%
VERACYTE INC (VCYT)
3.99%
IOVANCE BIOTHERAPEUTICS INC (IOVA)
3.89%
ARCTURUS THERAPEUTICS HOLDIN (ARCT UQ)
3.57%
COMPUGEN LTD (CGEN)
3.33%
IONIS PHARMACEUTICALS INC (IONS)
3.22%
REGENERON PHARMACEUTICALS (REGN)
3.15%
NANOSTRING TECHNOLOGIES INC (NSTG)
2.87%
CELLECTIS - ADR (CLLS)
2.85%
CAREDX INC (CDNA)
2.62%
INCYTE CORP (INCY)
2.47%
INOVIO PHARMACEUTICALS INC (INO)
2.4%
BRISTOL-MYERS SQUIBB CO (BMY)
2.3%
CODEXIS INC (CDXS)
2.18%
SYROS PHARMACEUTICALS INC (SYRS)
1.99%
GUARDANT HEALTH INC (GH)
1.83%
CERUS CORP (CERS)
1.75%
TWIST BIOSCIENCE CORP (TWST)
1.65%
SERES THERAPEUTICS INC (MCRB)
1.37%
CELLULAR BIOMEDICINE GROUP I (CBMG)
1.36%
FATE THERAPEUTICS INC (FATE)
1.26%
APPLE INC (AAPL)
1.08%
RUBIUS THERAPEUTICS INC (RUBY)
1.04%
PACIFIC BIOSCIENCES OF CALIF (PACB)
1.01%
PERSONALIS INC (PSNL)
0.98%
CASTLE BIOSCIENCES INC (CSTL)
0.97%
PLURISTEM THERAPEUTICS INC (PSTI)
0.51%
INTREXON CORP (XON)
0.47%
ORGANOVO HOLDINGS INC (ONVO)
0.39%
AQUABOUNTY TECHNOLOGIES (AQB)
0.23%
ARK Genomic Revolution Multi-Sector ETF (ARKG)
0%

ARKG Technicals

Alpha

7.22

Beta

1.93

Leverage

Long

Standard Deviation

2.67

ARKG Dividends

Dividend Date

2018-12-27

Latest Dividend

0.27

Annual Dividend

0.27

Annual Dividend Rate

0.27

Annual Dividend Yield

0.95

ARKG Performance

YTD Return

19.31%

1 Year Return

-1.68%

3 Year Return

61.72%

5 Year Return

0%

10 Year Return

42.09%

ARKG Related Articles

© 2019 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.

Fundamental company data provided by Morningstar and Zacks Investment Research. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.